Structural Basis for Potassium Inhibition of WNK Kinases
Biochemistry · 16.06.2026 · 65 (12) · 1922-1931
DOI: 10.1021/acs.biochem.5c00825 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemistry, online erschienen am 26.05.2026. Verfasst von Elizabeth J Goldsmith und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biophysics, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-8816, United States. Hauptthemen laut MEDLINE: Potassium, WNK Lysine-Deficient Protein Kinase 1, Protein Serine-Threonine Kinases, Protein Kinase Inhibitors. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases, Welch Foundation.
Abstract (Originalsprache)
WNK kinases are chloride- and osmotic-stress-regulated protein kinases recently shown to be controlled by potassium. Prior studies demonstrated the direct binding of chloride and osmotic stress-related water in WNK kinase regulation. Here, we probe potassium binding and regulation of WNK kinases via crystallography coupled with mutagenic analysis of WNK kinase autophosphorylation and activity. Crystals of unphosphorylated WNK1 grown in cesium formate, a surrogate for potassium, yielded nonsulfur scattering peaks at 5.75 keV. Mutations were introduced into amino acids flanking the anomalous diffraction peaks. Mutations in WNK1/E388 and the corresponding WNK3/E314, probing a peak close to WNK1/I384, led to reduced inhibition by potassium while maintaining kinase autophosphorylation and substrate phosphorylation activity. Other peaks probed by mutagenesis either did not bear out as potassium regulatory sites or were not validated due to the inactivity of the mutants synthesized. Previously synthesized chloride- and water-binding mutants demonstrate correlated sensitivity to chloride and potassium. Potassium, chloride, and water are all WNK inhibitors that share a common mechanism binding the same low-activity asymmetric dimer of WNK1 kinase domains.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biophysics, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-8816, United States.
- Molecular Medicine Program, University of Utah, Salt Lake City, Utah 84112, United States.
- Diamond Light Source, Harwell Science and Innovation Campus, Didcot OX11 0DE, U.K.
- Research Complex at Harwell, Rutherford Appleton Laboratory, Didcot OX11 0FA, U.K.
- Department of Internal Medicine, Division of Nephrology & Hypertension, University of Utah, Salt Lake City, Utah 84112, United States.
- Medical Service, Veterans Affairs Salt Lake City Health Care System, Salt Lake City, Utah 84143, United States.
ORCID-Profile: Elizabeth J Goldsmith, Vitaliy Mykhaylyk, Aylin R Rodan
Förderung
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- Welch Foundation
Zitieren
APA
Goldsmith, E. J., Pleinis, J. M., Wagner, A., Mykhaylyk, V., Akella, R., Humphreys, J. M., He, H., Norrell, L., Morrison, D. E., & Rodan, A. R. (2026). Structural Basis for Potassium Inhibition of WNK Kinases. Biochemistry, 65(12), 1922-1931. https://doi.org/10.1021/acs.biochem.5c00825
Vancouver
Goldsmith EJ, Pleinis JM, Wagner A, Mykhaylyk V, Akella R, Humphreys JM, et al. Structural Basis for Potassium Inhibition of WNK Kinases. Biochemistry. 2026;65(12):1922-1931. doi:10.1021/acs.biochem.5c00825
BibTeX
@article{Goldsmith2026,
author = {Goldsmith, Elizabeth J and Pleinis, John M and Wagner, Armin and Mykhaylyk, Vitaliy and Akella, Radha and Humphreys, John M and He, Haixia and Norrell, Logan and Morrison, Daryl E and Rodan, Aylin R},
title = {Structural Basis for Potassium Inhibition of WNK Kinases},
journal = {Biochemistry},
year = {2026},
volume = {65},
number = {12},
pages = {1922--1931},
doi = {10.1021/acs.biochem.5c00825}
}
EUVIMED